These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 34495438)
41. Can RENAL and PADUA nephrometry indices predict complications of laparoscopic cryoablation for clinical stage T1 renal tumors? Lagerveld BW; Brenninkmeijer M; van der Zee JA; van Haarst EP J Endourol; 2014 Apr; 28(4):464-71. PubMed ID: 24228738 [TBL] [Abstract][Full Text] [Related]
42. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes. Zhou W; Herwald SE; McCarthy C; Uppot RN; Arellano RS J Vasc Interv Radiol; 2019 Jul; 30(7):1035-1042. PubMed ID: 30956075 [TBL] [Abstract][Full Text] [Related]
43. Usefulness of R.E.N.A.L. nephrometry scoring system for predicting outcomes and complications of percutaneous ablation of 751 renal tumors. Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Boorjian SA; Carter RE; Geske JR; Callstrom MR; Atwell TD J Urol; 2013 Jan; 189(1):30-5. PubMed ID: 23164375 [TBL] [Abstract][Full Text] [Related]
44. The effectiveness of RENAL nephrometry score in ablated renal tumors via radiofrequency ablation or cryoablation. Aladağ Kurt S; Yücel C; Özhan Oktar S; Erbaş G; Sözen S; Öner AY Turk J Med Sci; 2019 Jun; 49(3):761-768. PubMed ID: 31062941 [TBL] [Abstract][Full Text] [Related]
46. Peri-operative and local control outcomes of robot-assisted partial nephrectomy vs percutaneous cryoablation for renal masses: comparison after matching on radiological stage and renal score. Fraisse G; Colleter L; Peyronnet B; Khene ZE; Mandoorah Q; Soorojebally Y; Bourgi A; De La Taille A; Roupret M; De Kerviler E; Desgrandchamps F; Bensalah K; Masson-Lecomte A BJU Int; 2019 Apr; 123(4):632-638. PubMed ID: 30153399 [TBL] [Abstract][Full Text] [Related]
47. Percutaneous radio frequency ablation of renal tumors in patients with von Hippel-Lindau disease: preliminary results. Park BK; Kim CK J Urol; 2010 May; 183(5):1703-7. PubMed ID: 20299060 [TBL] [Abstract][Full Text] [Related]
49. Percutaneous cryoablation of renal cell carcinoma guided by horizontal open magnetic resonance imaging. Miki K; Shimomura T; Yamada H; Kishimoto K; Ohishi Y; Harada J; Egawa S Int J Urol; 2006 Jul; 13(7):880-4. PubMed ID: 16882047 [TBL] [Abstract][Full Text] [Related]
50. Comparison of Contrast-Enhanced Ultrasound Scan (CEUS) and MRI in the follow-up of cryoablation for small renal tumors. Experience on 25 cases. Zeccolini G; Del Biondo D; Cicero C; Casarin A; Guarise A; Celia A Urologia; 2014; 81 Suppl 23():S1-8. PubMed ID: 24665032 [TBL] [Abstract][Full Text] [Related]
52. Cryoablation of Bone Metastases from Renal Cell Carcinoma for Local Tumor Control. Gardner CS; Ensor JE; Ahrar K; Huang SY; Sabir SH; Tannir NM; Lewis VO; Tam AL J Bone Joint Surg Am; 2017 Nov; 99(22):1916-1926. PubMed ID: 29135665 [TBL] [Abstract][Full Text] [Related]
53. Percutaneous Clinical T1a Renal Mass Ablation in the Octogenarian and Nonagenarian: Oncologic Outcomes and Morbidity. Miller AJ; Kurup AN; Schmit GD; Weisbrod AJ; Boorjian SA; Thompson RH; Lohse CM; Kor DJ; Callstrom MR; Atwell TD J Endourol; 2015 Jun; 29(6):671-6. PubMed ID: 25386995 [TBL] [Abstract][Full Text] [Related]
54. Image-guided percutaneous renal cryoablation: preoperative risk factors for recurrence and complications. Blute ML; Okhunov Z; Moreira DM; George AK; Sunday S; Lobko II; Vira MA BJU Int; 2013 Apr; 111(4 Pt B):E181-5. PubMed ID: 23107011 [TBL] [Abstract][Full Text] [Related]